| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT06409832 RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment |
Trial arms changed: 2 -> 1 |
| 2026-06-10 | NCT07609914 A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant… |
Recruitment opened |
| 2026-06-10 | NCT06616194 A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent… |
Trial sites reduced: 108 -> 103 locations |
| 2026-05-15 | NCT06616194 A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent… |
Trial sites expanded: 48 -> 107 locations |
| 2026-05-15 | NCT04743141 Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of… |
Trial sites expanded: 64 -> 126 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-29 | NCT07613788 Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCL | Phase 2 | Not Yet Recruiting |
| 2026-05-27 | NCT07609914 A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant… | Phase 4 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07609914 | A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant… | Acute Treatment of Migraine | Recruiting |
| Phase 3 | |||
| NCT04743141 | Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of… | Acute Treatment of Migraine | Recruiting |
| NCT05156398 | Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in… | Migraine | Recruiting |
| NCT06616194 | A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent… | Migraine | Recruiting |
| NCT06641466 | A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for… | Menstrual Migraine | Recruiting |
| Phase 2/3 | |||
| NCT07435090 | Efficacy and Safety of Rimegepant for Acute Dizziness | Dizziness | Not Yet Recruiting |
| Phase 2 | |||
| NCT07613788 | Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCL | Relapsed/Refractory Large B-cell Lymphoma (LBCL) | Not Yet Recruiting |
| Not specified | |||
| NCT05903027 | Gepant treAtments: EffectIveNess and tolERability (GAINER) | Migraine | Recruiting |
| NCT06409832 | RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment | Migraine | Recruiting |
| NCT05198245 | Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy | Migraine | Active, Not Recruiting |
| NCT06439628 | ARISE-A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine | Migraine | Active, Not Recruiting |